SCHEMBL20174271

SCHEMBL20174271

c1ccc(-c2cc(-c3ccc(-c4ccc5c(c4)C4(c6ccccc6-c6ccccc64)c4c-5oc5ccccc45)cc3)cc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
PDK2 Q15119 7/20 0.35
ANO1 Q5XXA6 1/20 0.35
PIM1 P11309 1/20 0.34
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
CTRC Q99895 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
CYP1A2 P05177 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30
PLA2G2A P14555 1/20 0.30
PLA2G4A P47712 1/20 0.30
ADORA2A P29274 1/20 0.30
ADORA2B P29275 1/20 0.30
ADORA1 P30542 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22326570 0.95 CYP1A1 (0.34) CYP1A1CYP1B1PDK2ANO1PIM1
SCHEMBL20174284 0.94 PDK2 (0.39) PDK2KMT2AMAPK1PLA2G2APLA2G4A
SCHEMBL20174261 0.93 CYP1A1 (0.39) CYP1A1CYP1B1PDK2ANO1PIM1
SCHEMBL20174267 0.93 CYP1A1 (0.36) CYP1A1CYP1B1PDK2ANO1PIM1
SCHEMBL20174199 0.92 PDK2 (0.36) PDK2KMT2AMAPK1ALDH1A1MAPT
SCHEMBL20174209 0.91 PDK2 (0.36) PDK2KMT2AMAPK1ALDH1A1MAPT
SCHEMBL20174255 0.90 CYP1A1 (0.38) CYP1A1CYP1B1PDK2ANO1PIM1
SCHEMBL20174710 0.89 PDK2 (0.34) PDK2KMT2AMAPK1
SCHEMBL20174277 0.88 PIM1 (0.36) CYP1A1CYP1B1PIM1KMT2ACTRC
SCHEMBL20174202 0.88 PDK2 (0.36) PDK2KMT2AMAPK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG CYP1A1 726/4885CYP1B1 725/4885PDK2 651/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG CYP1A1 726/4885CYP1B1 725/4885PDK2 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.